US stock · Healthcare sector · Pharmaceutical Retailers

Walgreens Boots Alliance, Inc.

WBA

NASDAQ

30.01

USD

+0.04

(+0.13%)

Market Closed

-7.22P/E

6Forward P/E

-0.30P/E to S&P500

25.893BMarket CAP

6.40%Div Yield

Summary Financials Transcripts Monitoring Classic View

Upcoming Earnings

28 Jun-3 Jul

Shares Short

5/15/23

30.25M

Short % of Float

4.23%

Short % of Shares Outs.

3.51%

% Held by Insiders

17.18%

% Held by Institutions

61.64%

Beta

0.71

PEG Ratio

3.84

52w. high/low

44.27/29.48

Avg. Daily Volume

7.10M

Return %

Stock

S&P 500

1 year

(30.77)

2.11

3 years

(29.54)

38.05

5 years

(52.87)

54.53

Scale: |

High

Low

39.00

21.28

40.69

21.39

40.20

26.26

47.11

30.34

37.75

28.53

60.93

37.06

77.98

55.27

97.30

73.00

102.82

71.50

88.00

63.82

86.31

59.07

74.94

49.03

59.78

33.36

57.05

39.94

55.00

30.39

37.95

29.48

Currency: USD

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

TTM

Revenue per share

53.84

59.59

63.97

68.68

78.88

81.89

76.34

80.15

99.16

108.35

110.12

132.73

148.53

158.67

153.23

153.52

154.33

Earnings per share

2.04

2.18

2.03

2.13

2.97

2.43

2.59

2.03

4.05

3.85

3.80

5.07

4.32

0.52

2.94

5.02

(4.15)

FCF per share

0.57

0.82

2.21

2.78

2.66

3.29

3.27

2.92

4.23

6.02

5.50

6.96

4.22

4.67

4.83

2.50

1.14

Dividends per share

0.31

0.38

0.45

0.55

0.71

0.90

1.10

1.26

1.33

1.44

1.61

1.75

1.78

1.99

1.87

1.92

CAPEX per share

1.79

2.25

1.95

1.03

1.33

1.77

1.28

1.16

1.20

1.22

1.26

1.38

1.85

1.56

1.59

2.01

2.28

Book Value per sh.

11.12

12.99

14.52

14.67

16.22

20.85

20.56

21.46

29.58

27.59

25.59

26.24

25.51

23.47

27.08

33.97

31.74

Comm.Shares outs.

999

991

990

982

915

875

946

953

1,043

1,083

1,074

991

922

879

865

864

Avg. annual P/E ratio

21.4

15.1

15.6

15.7

13.1

14.0

19.0

32.7

21.0

21.2

20.8

13.9

13.6

82.5

17.0

8.3

(7.2)

P/E to S&P500

1.2

0.7

0.2

0.8

0.9

1.1

1.8

1.0

0.9

0.6

2.2

0.6

0.4

(0.3)

Avg. annual div. yield

0.7%

1.2%

1.4%

1.6%

1.8%

2.6%

2.2%

1.9%

1.6%

1.8%

2.0%

2.5%

3.0%

4.6%

3.7%

4.6%

5.3%

Revenue (m)

53,762

59,034

63,335

67,420

72,184

71,633

72,217

76,392

103,444

117,351

118,214

131,537

136,866

139,537

132,509

132,703

133,290

Operating margin

5.9%

5.8%

5.1%

6.0%

4.8%

5.5%

4.5%

5.1%

4.7%

4.9%

3.7%

0.9%

1.8%

1.0%

(4.7)%

Depreciation (m)

676

840

975

1,030

1,086

1,166

1,283

1,316

1,742

1,718

1,654

1,770

2,038

1,927

1,973

1,990

2,835

Net profit (m)

2,041

2,157

2,006

2,091

2,714

2,127

2,450

1,932

4,220

4,173

4,078

5,024

3,982

456

2,542

4,337

(3,585)

Income tax rate

36.0%

37.1%

36.6%

38.0%

36.8%

37.0%

37.1%

42.9%

19.9%

19.4%

15.7%

16.7%

13.0%

48.5%

33.4%

0.7%

353.6%

Net profit margin

3.8%

3.7%

3.2%

3.1%

3.8%

3.0%

3.4%

2.5%

4.1%

3.6%

3.4%

3.8%

2.9%

0.3%

1.9%

3.3%

(2.7)%

Working capital (m)

2,766

3,790

5,280

4,489

4,239

2,038

2,991

3,347

3,100

8,870

1,206

(3,821)

(7,069)

(8,997)

(6,240)

(5,681)

(10,539)

Long-term debt (m)

- -

1,337

2,336

2,389

2,396

4,073

4,477

3,736

13,315

18,705

12,684

12,431

11,098

12,203

29,828

32,132

31,015

Equity (m)

11,104

12,869

14,376

14,400

14,847

18,236

19,454

20,457

30,861

29,880

27,466

26,007

23,512

20,637

23,419

29,366

29,439

ROIC

16.2%

13.7%

11.2%

11.4%

14.2%

8.8%

9.6%

7.3%

9.1%

8.4%

10.0%

12.1%

11.1%

1.3%

4.7%

7.0%

22.0%

Return on capital

16.5%

15.3%

12.9%

13.2%

15.9%

10.4%

11.4%

9.7%

8.6%

8.0%

8.5%

9.8%

7.9%

1.7%

5.1%

5.3%

(6.2)%

Return on equity

18.4%

16.8%

14.0%

14.5%

18.3%

11.7%

12.6%

9.4%

13.7%

14.0%

14.8%

19.3%

16.9%

2.2%

10.9%

14.8%

(12.2)%

Plowback ratio

84.8%

82.6%

77.8%

74.1%

76.2%

63.0%

57.6%

37.9%

67.2%

62.5%

57.7%

65.4%

58.7%

(283.1)%

36.4%

59.2%

146.7%

Div.&Repurch./FCF

193.8%

56.5%

33.2%

84.1%

110.1%

68.7%

53.6%

68.3%

59.1%

41.6%

117.7%

101.0%

149.1%

81.2%

41.4%

76.6%

- -

Capital Structure

28 Mar · 2023 | Q2

All numbers in millions

Total liabilities

$ 70,882

Total assets

$ 100,479

Long-term debt

$ 31,015

Cash and equiv.

$ 1,088

Goodwill

$ 28,343

Retained earnings

$ 33,952

Common stock

863

Enterprise Value

$ 55,820

Working Capital

Currency: USD, in millions

2020

2021

2022

Cash & Investments

516

1,193

2,472

Receivables

7,132

5,663

5,017

Inventory

9,451

8,159

8,353

Other

974

1,476

1,902

Current assets

18,073

15,814

16,902

Acc. Payable

14,458

11,136

11,255

Debt due

5,965

3,565

3,345

Other

6,647

7,353

7,983

Current liabilities

27,070

22,054

22,583

Annual growth rates

(avg. rate of change)

1 year

5 years

10 years

Revenue

0.15%

0.28%

7.53%

Cash flow

(48.16)%

(21.13)%

2.13%

Earnings

70.61%

104.70%

59.54%

Dividends

2.60%

(1.01)%

5.64%

Book value

25.39%

4.26%

6.28%

Insider Trading

Type

Date

Walgreens Boots Alliance, Inc.

Sale

292,792

05/11/23

Walgreens Boots Alliance, Inc.

Other

918,000

05/11/23

Walgreens Boots Alliance, Inc.

Other

1.84mln.

05/11/23

Kehoe James

InKind

6,020

05/01/23

Gates Richard P.

- -

04/20/23

Quarterly Revenue

Currency: USD, in millions

Year

Total

2021

36,307

32,779

34,030

34,262

137,378

2022

33,901

33,756

32,597

32,449

132,703

2023

33,382

34,862

- -

Earnings per share

Currency: USD

Year

Total

2021

(0.36)

1.19

1.38

0.73

2.94

2022

4.09

1.02

0.26

(0.61)

4.77

2023

(4.43)

0.62

- -

Quarterly dividends paid

Currency: USD

Year

Total

2021

0.47

1.87

2022

0.48

0.49

0.48

0.47

1.92

2023

0.48

- -

Company Description

Sector:

Healthcare

Industry:

Pharmaceutical Retailers

CEO:

Ms. Rosalind Gates Brewer

Full-time employees:

200,000

City:

Deerfield

Address:

108 Wilmot Road

IPO:

Dec 31, 2014

CIK:

0001618921

Website:

walgreensbootsalliance.com

Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores. It also provides central specialty pharmacy services and mail services. As of August 31, 2021, this segment operated 8,965 retail stores under the Walgreens and Duane Reade brands in the United States; and five specialty pharmacies. The International segment sells prescription drugs; and health and wellness, beauty, personal care, and other consumer products through its pharmacy-led health and beauty retail stores and optical practices, as well as through boots.com and an integrated mobile application. It also engages in pharmaceutical wholesaling and distribution business in Germany. As of August 31, 2021, this segment operated 4,031 retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile; and 548 optical practices, including 160 on a franchise basis. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.

Powered by AI

Walgreens Boots Alliance, Inc.

30.01